2
Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-186979
Dated February 24, 2015

Eli Lilly and Company
Pricing Term Sheet
1.250% Notes due 2018
2.750% Notes due 2025
3.700% Notes due 2045
Issuer:
Eli Lilly and Company
 
 
 
 
Principal Amount:
$600,000,000
$800,000,000
$800,000,000
 
 
 
 
Maturity Date:
March 1, 2018
June 1, 2025
March 1, 2045
 
 
 
 
Coupon:
1.250% per year
2.750% per year
3.700% per year
 
 
 
 
Public Offering Price:
99.912% of principal amount
99.807% of principal amount
99.515% of principal amount
 
 
 
 
Yield to Maturity:
1.280%
2.772%
3.727%
 
 
 
 
Benchmark Treasury:
1.000% due February 15, 2018
2.000% due February 15, 2025
3.000% due November 15, 2044
 
 
 
 
Spread to Benchmark Treasury:
T+32 bps
T+80 bps
T+115 bps
 
 
 
 
Benchmark Treasury Price / Yield:
100-03 3/4 / 0.960%
100-08 / 1.972%
108-24 / 2.577%
 
 
 
 
Interest Payment Dates:
March 1 and September 1,
commencing September 1, 2015
June 1 and December 1,
commencing June 1, 2015
(short first coupon)
March 1 and September 1, commencing September 1, 2015
 
 
 
 
Redemption Provisions:
 
 
 
Make-whole call:
Make whole plus 5 bps
Prior to March 1, 2025,
make whole plus 15 bps
(calculated to the par call date)
Prior to September 1, 2044,
make whole plus 20 bps
(calculated to the par call date)
Par call:
Not applicable
On or after March 1, 2025,
at 100%
On or after September 1, 2044,
at 100%
 
 
 
 
CUSIP / ISIN:
532457 BK3 / US532457BK39
532457 BH0 / US532457BH00
532457 BJ6 / US532457BJ65
 
 
 
 
Trade Date:
February 24, 2015
 
 
 
 
Settlement Date:
March 5, 2015 (T+7)
 
 
 
 
Denominations:
$2,000 x $1,000
 
 
 
 
Joint Book-Running Managers:
Deutsche Bank Securities Inc., Goldman, Sachs & Co., Morgan Stanley & Co. LLC and
Merrill Lynch, Pierce, Fenner & Smith Incorporated
 
 
 





Co-Managers:
Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC, UBS Securities LLC and
Drexel Hamilton, LLC
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Deutsche Bank Securities Inc. toll-free at (800) 503-4611, Goldman, Sachs & Co. toll-free at (866) 471-2526, Morgan Stanley & Co. LLC toll-free at (866) 718-1649 and Merrill Lynch, Pierce, Fenner & Smith Incorporated toll-free at (800) 294-1322.












































2


Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Eli Lilly Charts.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Eli Lilly Charts.